Epigenetic age acceleration in follicular fluid and markers of ovarian response among women undergoing IVF
Human Reproduction · 01.09.2024 · 39 (9) · 2003-2009
DOI: 10.1093/humrep/deae136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 18.06.2024. Verfasst von Robert B Hood und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Fertilization in Vitro, Ovulation Induction, Epigenesis, Genetic, Follicular Fluid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, Emory University NIH Training, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
STUDY QUESTION Are markers of epigenetic age acceleration in follicular fluid associated with outcomes of ovarian stimulation? SUMMARY ANSWER Increased epigenetic age acceleration of follicular fluid using the Horvath clock, but not other epigenetic clocks (GrimAge and Granulosa Cell), was associated with lower peak estradiol levels and decreased number of total and mature oocytes. WHAT IS KNOWN ALREADY In granulosa cells, there are inconsistent findings between epigenetic age acceleration and ovarian response outcomes. STUDY DESIGN, SIZE, DURATION Our study included 61 women undergoing IVF at an academic fertility clinic in the New England area who were part of the Environment and Reproductive Health Study (2006–2016). PARTICIPANTS/MATERIALS, SETTING, METHODS Participants provided a follicular fluid sample during oocyte retrieval. DNA methylation of follicular fluid was assessed using a genome-wide methylation screening tool. Three established epigenetic clocks (Horvath, GrimAge, and Granulosa Cell) were used to predict DNA-methylation-based epigenetic age. To calculate the age acceleration, we regressed epigenetic age on chronological age and extracted the residuals. The association between epigenetic age acceleration and ovarian response outcomes (peak estradiol levels, follicle stimulation hormone, number of total, and mature oocytes) was assessed using linear and Poisson regression adjusted for chronological age, three surrogate variables (to account for cellular heterogeneity), race, smoking status, initial infertility diagnosis, and stimulation protocol. MAIN RESULTS AND ROLE OF CHANCE Compared to the median chronological age of our participants (34 years), the Horvath clock predicted, on an average, a younger epigenetic age (median: 24.2 years) while the GrimAge (median: 38.6 years) and Granulosa Cell (median: 39.0 years) clocks predicted, on an average, an older epigenetic age. Age acceleration based on the Horvath clock was associated with lower peak estradiol levels (−819.4 unit decrease in peak estradiol levels per standard deviation increase; 95% CI: −1265.7, −373.1) and fewer total (% change in total oocytes retrieved per standard deviation increase: −21.8%; 95% CI: −37.1%, −2.8%) and mature oocytes retrieved (% change in mature oocytes retrieved per standard deviation increase: −23.8%; 95% CI: −39.9%, −3.4%). The age acceleration based on the two other epigenetic clocks was not associated with markers of ovarian response. LIMITATIONS, REASONS FOR CAUTION Our sample size was small and we did not specifically isolate granulosa cells from follicular fluid samples so our samples could have included mixed cell types. WIDER IMPLICATIONS OF THE FINDINGS Our results highlight that certain epigenetic clocks may be predictive of ovarian stimulation outcomes when applied to follicular fluid; however, the inconsistent findings for specific clocks across studies indicate a need for further research to better understand the clinical utility of epigenetic clocks to improve IVF treatment. STUDY FUNDING/COMPETING INTEREST(S) The study was supported by grants ES009718, ES022955, ES000002, and ES026648 from the National Institute of Environmental Health Sciences (NIEHS) and a pilot grant from the NIEHS-funded HERCULES Center at Emory University (P30 ES019776). RBH was supported by the Emory University NIH Training Grant (T32-ES012870). TRIAL REGISTRATION NUMBER N/A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
- Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, GA, USA.
ORCID-Profile: Robert B Hood, Todd M Everson, Anna Knight, Audrey J Gaskins
Förderung
- NIEHS NIH HHS
- Emory University NIH Training
- National Institute of Environmental Health Sciences
- NIEHS-funded HERCULES Center at Emory University
Zitieren
APA
Hood, R. B., Everson, T. M., Ford, J. B., Hauser, R., Knight, A., Smith, A. K., & Gaskins, A. J. (2024). Epigenetic age acceleration in follicular fluid and markers of ovarian response among women undergoing IVF. Human Reproduction, 39(9), 2003-2009. https://doi.org/10.1093/humrep/deae136
Vancouver
Hood RB, Everson TM, Ford JB, Hauser R, Knight A, Smith AK, et al. Epigenetic age acceleration in follicular fluid and markers of ovarian response among women undergoing IVF. Human Reproduction. 2024;39(9):2003-2009. doi:10.1093/humrep/deae136
BibTeX
@article{Hood2024,
author = {Hood, Robert B and Everson, Todd M and Ford, Jennifer B and Hauser, Russ and Knight, Anna and Smith, Alicia K and Gaskins, Audrey J},
title = {Epigenetic age acceleration in follicular fluid and markers of ovarian response among women undergoing IVF},
journal = {Human Reproduction},
year = {2024},
volume = {39},
number = {9},
pages = {2003--2009},
doi = {10.1093/humrep/deae136}
}
EUVIMED